Monoclonal Antibodies
Anti-PSMA/FOLH1 Monoclonal Antibody for WB, IHC-P, ELISA - Q04609
Item Number : CM0007574
Price varies based on specs and customizations
- Application
- WB, IHC-P, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 84kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | PSMA/FOLH1 Rabbit mAb |
| Remarks/Alias | PSM; FGCP; FOLH; GCP2; PSMA; mGCP; GCPII; NAALAD1; PSMA/FOLH1 |
| Species | Human |
| GeneID (Human) | 2346 |
| GeneID | 2346 |
| Immunogen | Synthetic peptide|A synthetic peptide corresponding to a sequence within amino acids 50-150 of human PSMA/FOLH1 (NP_004467.1). |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, IHC-P, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | Q04609 |
| Protein Weight | 84kDa |
| Shipping | Ice bag |
Biological Background: PSMA/FOLH1 Function and Localization
- PSMA/FOLH1 (Glutamate carboxypeptidase 2) is a multifunctional enzyme that possesses both folate hydrolase and N-acetylated-alpha-linked acidic dipeptidase (NAALADase) activity, with preference for tri-alpha-glutamate peptides.
- In the intestine, it facilitates folate absorption by cleaving polyglutamated folates, while in the brain, it modulates glutamatergic neurotransmission by hydrolyzing the neuropeptide NAAG to release glutamate.
- The protein is involved in prostate tumor progression, and isoform-specific expression has been observed: PSMA' predominates in normal prostate, PSMA-1 in primary tumors, and PSMA-9 is specifically expressed in prostate cancer.
- Subcellularly, it is anchored to the cell membrane via a signal-anchor transmembrane domain, but also localizes to the cytoplasm.
- It additionally exhibits dipeptidyl-peptidase IV-like activity, cleaving substrates such as Gly-Pro-AMC in vitro.
- As a zinc-dependent metalloprotease, it requires zinc and calcium for catalytic function and undergoes glycosylation and phosphorylation, contributing to an apparent molecular weight higher than the predicted 84 kDa.
- Tissue distribution is broad but highest in prostate epithelium, with significant expression also in kidney, brain, small intestine, and various tumor endothelia.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide from the extracellular domain (aa 50-150) of human PSMA/FOLH1, which is accessible in native and denaturing conditions, supporting its use in WB, IHC-P, and ELISA applications.
- In western blotting, note that glycosylation may cause the band to migrate at 100–120 kDa rather than the predicted 84 kDa; validate the observed band using positive controls or knockdown/knockout samples.
- For IHC-P, antigen retrieval with citrate or EDTA buffer (pH 6.0–9.0) is often beneficial; titration and optimization in the relevant tissue type are recommended.
- Cross-reactivity with mouse and rat allows preclinical studies in common models; confirm endogenous expression levels in the tissue/cell line of interest before large-scale experiments.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your dedicated partner for IVD raw-material sourcing, bridging the gap from concept to clinic with a comprehensive portfolio tailored to diagnostic developers. For research areas centered on PSMA/FOLH1—such as prostate cancer diagnostics, neurobiology, and folate metabolism—we supply validated antibody pairs, optimized rabbit monoclonal antibodies like this anti-PSMA/FOLH1 clone, and auxiliary reagents to support your assay development. Whether you need bulk raw materials or rare-target reagents, our one-stop service model streamlines procurement so you can focus on translating discoveries into reliable diagnostic tests.
Product Datasheet
Anti-PSMA/FOLH1 Monoclonal Antibody for WB, IHC-P, ELISA - Q04609
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!